Zobrazeno 1 - 10
of 29
pro vyhledávání: ''
Autor:
Martine Escoffre-Barbe, P. Rousselot, Pascale Cony-Makhoul, Stéphane Bouchet, Lambert Busque, Caroline Dartigeas, Franck E. Nicolini, Valérie Coiteux, Françoise Huguet, Laurence Legros, Lydia Roy, Delphine Rea, François Guilhot, Joelle Guilhot, Emilie Cayssials, Francois-Xavier Mahon, Luigina Mollica, Agnès Guerci, Martine Gardembas, Jean-Michel Cayuela, Anne Bergeron, Gabriel Etienne, Viviane Dubruille, Aude Charbonnier, Mathieu Molimard
Publikováno v:
British Journal of Haematology
British Journal of Haematology, Wiley, 2021, 194 (2), pp.393-402. ⟨10.1111/bjh.17654⟩
British Journal of Haematology, 2021, 194 (2), pp.393-402. ⟨10.1111/bjh.17654⟩
British Journal of Haematology, Wiley, 2021, 194 (2), pp.393-402. ⟨10.1111/bjh.17654⟩
British Journal of Haematology, 2021, 194 (2), pp.393-402. ⟨10.1111/bjh.17654⟩
International audience; Dasatinib is a second-generation BCR-ABL1 tyrosine kinase inhibitor approved for patients with chronic myeloid leukaemia (CML). Dasatinib 100 mg per day is associated with an increased risk of pleural effusion (PlEff). We rand
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ccf07937e7bb76172bb58c0cabbf6bd0
https://hal.archives-ouvertes.fr/hal-03324903
https://hal.archives-ouvertes.fr/hal-03324903
Autor:
null Matthieu Mahévas, null Imane Azzaoui, null Etienne Crickx, null Florence Canoui-Poitrine, null Delphine Gobert, null Laetitia Languille, null Nicolas Limal, null Constance Guillaud, null Laure Croisille, null Mohamed Jeljeli, null Fréderic Batteux, null Samia Baloul, null Olivier Fain, null France Pirenne, null Jean-Claude Weill, null Claude-Agnès Reynaud, null Bertrand Godeau, null Marc Michel
Publikováno v:
Haematologica
Haematologica, Ferrata Storti Foundation, 2020, pp.haematol.2020.259481. ⟨10.3324/haematol.2020.259481⟩
Haematologica, 2020, pp.haematol.2020.259481. ⟨10.3324/haematol.2020.259481⟩
Haematologica, Ferrata Storti Foundation, 2020, pp.haematol.2020.259481. ⟨10.3324/haematol.2020.259481⟩
Haematologica, 2020, pp.haematol.2020.259481. ⟨10.3324/haematol.2020.259481⟩
International audience; B-cell activating factor may be involved in the failure of B-cell depleting therapy with rituximab in immune thrombocytopenia (ITP) by promoting the emergence of splenic long-lived plasma cells. From results obtained in mouse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e6083307a6537e6fad0ef09fa989c72
https://hal.archives-ouvertes.fr/hal-03127043
https://hal.archives-ouvertes.fr/hal-03127043
Autor:
Nagesh Kalakonda, Günter Fingerle-Rowson, Marc André, Eva González Barca, Sumeet Ambarkhane, Zsolt Nagy, Aleš Obr, Gilles Salles, Olivier Tournilhac, Kami J. Maddocks, Gianluca Gaidano, Johannes Duell, Maren Dirnberger-Hertweck, Anna Marina Liberati, Johannes Weirather, Wojciech Jurczak, Martin Dreyling
Publikováno v:
The Lancet Oncology
The Lancet Oncology, 2020, 21 (7), pp.978-988. ⟨10.1016/S1470-2045(20)30225-4⟩
The Lancet. Oncology, Vol. 21, no. 7, p. 978-988 (2020)
Lancet Oncology
Lancet Oncology, Elsevier, 2020, 21 (7), pp.978-988. ⟨10.1016/S1470-2045(20)30225-4⟩
The Lancet Oncology, 2020, 21 (7), pp.978-988. ⟨10.1016/S1470-2045(20)30225-4⟩
The Lancet. Oncology, Vol. 21, no. 7, p. 978-988 (2020)
Lancet Oncology
Lancet Oncology, Elsevier, 2020, 21 (7), pp.978-988. ⟨10.1016/S1470-2045(20)30225-4⟩
Summary Background Patients with relapsed or refractory diffuse large B-cell lymphoma who are ineligible for autologous stem-cell transplantation have poor outcomes and few treatment options. Tafasitamab (MOR208) is an Fc-enhanced, humanised, anti-CD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e924b5648e9c49e092c3b777842021f
https://hal.archives-ouvertes.fr/hal-02935846
https://hal.archives-ouvertes.fr/hal-02935846
Autor:
Semplicini, C., de Antonio, M., Taouagh, N., Béhin, A., Bouhour, F., Echaniz-Laguna, A., Magot, A., Nadaj-Pakleza, A., Orlikowski, D., Sacconi, S., Salort-Campana, E., Solé, G., Tard, Celine, Zagnoli, F., Jean-Yves, H., Hamroun, D., Laforêt, P., Attarian, S., Aubé-Nathier, A. C., Arrassi, A., Bassez, G., Bedat-Millet, A. L., Bouibede, F., Boyer, F. C., Caillaud, C., Canal, A., Carlier, R. Y., Chanson, J. B., Chapon, F., Cintas, P., Deibener-Kaminsky, J., Demurger, F., Desnuelle, C., Durieu, I., Eymard, B., Feasson, L., Fournier, M., Froissart, R., Furby, A., Garcia, P. Y., Germain, D. P., Ghorab, K., Morales, R. J., Krim, E., Labauge, P., Lacour, A., Lagrange, E., Lefeuvre, C., Leguy-Seguin, V., Leonard-Louis, S., Magy, L., Masseau, A., Michaud, M., Minot-Myhié, M. C., Nicolas, G., Nollet, S., Not, A., Noury, J. B., Ollivier, G., Péréon, Y., Perez, Thierry, Perniconi, B., Piraud, M., Petiot, P., Pouget, J., Praline, J., Prigent, H., Renard, D., Spinazzi, M., Stojkovic, T., Taithe, F., Tiffreau, Vincent, Vincent, D.
Publikováno v:
Journal of Inherited Metabolic Disease
Journal of Inherited Metabolic Disease, 2020, Journal of Inherited Metabolic Disease, ⟨10.1002/jimd.12272⟩
Journal of Inherited Metabolic Disease, 2020, Journal of Inherited Metabolic Disease, ⟨10.1002/jimd.12272⟩
Despite a wide clinical spectrum, the adult form of Pompe disease is the most common one, and represents more than 90% of diagnosed patients in France. Since the marketing of enzyme replacement therapy (alglucosidase alfa, Myozyme), all reports to da
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef452b5fe44e007bddb88831d498f8c1
https://hal.univ-lille.fr/hal-04111774
https://hal.univ-lille.fr/hal-04111774
Autor:
Patrik M. Bavoil, Katrina Mark, Larry J. Forney, Mishka Terplan, Anne C. M. Thiébaut, Rebecca M. Brotman, Elisabeth Delarocque-Astagneau, Bing Ma, Jeanne Tamarelle, Jacques Ravel, Pawel Gajer, Michael S. Humphrys
Publikováno v:
Journal of Infectious Diseases
Journal of Infectious Diseases, 2020, 221 (4), pp.627-635. ⟨10.1093/infdis/jiz499⟩
The Journal of infectious diseases, vol 221, iss 4
Journal of Infectious Diseases, Oxford University Press (OUP), 2020, 221 (4), pp.627-635. ⟨10.1093/infdis/jiz499⟩
The Journal of Infectious Diseases
Journal of Infectious Diseases, 2020, 221 (4), pp.627-635. ⟨10.1093/infdis/jiz499⟩
The Journal of infectious diseases, vol 221, iss 4
Journal of Infectious Diseases, Oxford University Press (OUP), 2020, 221 (4), pp.627-635. ⟨10.1093/infdis/jiz499⟩
The Journal of Infectious Diseases
We characterized the composition and structure of the vaginal microbiota in a cohort of 149 women with genital Chlamydia trachomatis infection at baseline who were followed quarterly for 9 months after antibiotic treatment. At time of diagnosis, the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc94ddf45ba07106e0bc28a65ca75bee
https://hal.science/hal-03228157/document
https://hal.science/hal-03228157/document
Autor:
Maria Pilar Gallego Hernanz, Olivier Lortholary, Lucienne Chatenoud, Sophie Candon, Blandine Rammaert, Anne Perrine Foray, Baptiste Moreira
Publikováno v:
Journal of Infectious Diseases
Journal of Infectious Diseases, 2019, ⟨10.1093/infdis/jiz688⟩
Journal of Infectious Diseases, Oxford University Press (OUP), 2019, ⟨10.1093/infdis/jiz688⟩
Journal of Infectious Diseases, 2019, ⟨10.1093/infdis/jiz688⟩
Journal of Infectious Diseases, Oxford University Press (OUP), 2019, ⟨10.1093/infdis/jiz688⟩
Background Chronic disseminated candidiasis (CDC) is a rare disease that mostly occurs after chemotherapy-induced prolonged neutropenia in patients with hematological malignancies. It is believed to ensue from Candida colonization, breach of the inte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea4891d3bf7d915c99d534048e5f3317
https://hal.science/hal-02430509
https://hal.science/hal-02430509
Autor:
Thierry Lequerré, Marie Kozyreff, Sandra Desouches, Sophie Pouplin, Nicolas Sens, Gilles Avenel, Pascal Rottenberg, Julia Nicolau, Olivier Vittecoq
Publikováno v:
BMJ Open
BMJ Open, BMJ Publishing Group, 2019, 9 (12), pp.e031467. ⟨10.1136/bmjopen-2019-031467⟩
BMJ Open, BMJ Publishing Group, 2019, 9 (12), pp.e031467. ⟨10.1136/bmjopen-2019-031467⟩
ObjectiveTo determine predictive/predictable factors of relapse in rheumatoid arthritis (RA) patients undergoing biologic Disease-Modifying Anti-Rheumatic Drugs (bDMARDs) dose reduction/discontinuation.Patients and methodsRA patients receiving the sa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05ab2773c525901194310bc20cb2f647
https://hal.archives-ouvertes.fr/hal-02430620
https://hal.archives-ouvertes.fr/hal-02430620
Autor:
Anais Domergue, Odile Mercereau-Puijalon, Rithea Leang, Malen Ken, Dysoley Lek, Johann Beghain, Benoit Witkowski, Nimol Khim, Kaknika Loch, Rekol Huy, Frédéric Ariey, Saorin Kim, Chanra Khean, Nimol Kloeung, Valentine Duru, Rotha Eam, Philippe J Guerin, Sophy Chy, Didier Menard, Sopheakvatey Ke
Publikováno v:
BMC Medicine
BMC Medicine, BioMed Central, 2015, 13 (1), pp.305. ⟨10.1186/s12916-015-0539-5⟩
BMC Medicine, 2015, 13 (1), pp.305. ⟨10.1186/s12916-015-0539-5⟩
BMC Medicine, BioMed Central, 2015, 13 (1), pp.305. ⟨10.1186/s12916-015-0539-5⟩
BMC Medicine, 2015, 13 (1), pp.305. ⟨10.1186/s12916-015-0539-5⟩
Background The declining efficacy of dihydroartemisinin-piperaquine against Plasmodium falciparum in Cambodia, along with increasing numbers of recrudescent cases, suggests resistance to both artemisinin and piperaquine. Available in vitro piperaquin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2859730365064376e124365485e9dce
https://hal.archives-ouvertes.fr/hal-02560638/document
https://hal.archives-ouvertes.fr/hal-02560638/document
Autor:
Nic Van Dyck, Thomas Brucke, Claire Haegelen, Lilly Chen, Esther Suarez, Domenico Servello, Mauro Porta, Lars Timmermann, Michael T. Barbe, Iris Kaiser, Mohamed Maarouf, Sebastian Beirer, Fernando Sejio, Steven Gill, Alan L Whone, Roshini Jain, Niels Allert, Marc Vérin, François Alesch, Beatriz Lozano
Publikováno v:
The Lancet Neurology
The Lancet Neurology, Elsevier, 2015, 14 (7), pp.693-701. ⟨10.1016/S1474-4422(15)00087-3⟩
The Lancet Neurology, 2015, 14 (7), pp.693-701. ⟨10.1016/S1474-4422(15)00087-3⟩
The Lancet Neurology, Elsevier, 2015, 14 (7), pp.693-701. ⟨10.1016/S1474-4422(15)00087-3⟩
The Lancet Neurology, 2015, 14 (7), pp.693-701. ⟨10.1016/S1474-4422(15)00087-3⟩
International audience; Background High-frequency deep brain stimulation (DBS) with a single electrical source is effective for motor symptom relief in patients with Parkinson's disease. We postulated that a multiple-source, constant-current device t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e49db8ef4d734e302dc2340e77b286f5
https://hal-univ-rennes1.archives-ouvertes.fr/hal-01158658
https://hal-univ-rennes1.archives-ouvertes.fr/hal-01158658
Autor:
Boursiquot, Jean-Nicolas, Gérard, Laurence, Malphettes, Marion, Fieschi, Claire, Galicier, Lionel, Boutboul, David, Borie, Raphael, Viallard, Jean-François, Soulas-Sprauel, Pauline, Berezne, Alice, Jaccard, Arnaud, Hachulla, Eric, Haroche, Julien, Schleinitz, Nicolas, Têtu, Laurent, Oksenhendler, Eric, Renseigné, Non
Publikováno v:
Journal of Clinical Immunology
Journal of Clinical Immunology, Springer Verlag, 2013, 33 (1), pp.84-95. ⟨10.1007/s10875-012-9778-9⟩
Journal of Clinical Immunology, Springer Verlag, 2013, 33 (1), pp.84-95. ⟨10.1007/s10875-012-9778-9⟩
International audience; BACKGROUND: Granulomatous disease (GD) will develop in a subset of patients with common variable immunodeficiency (CVID). Little is known about the efficacy of therapeutic agents used for treating this disorder. OBJECTIVE: To
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96fa632007e1c7119856bf5859393b0f
https://hal.archives-ouvertes.fr/hal-00945425
https://hal.archives-ouvertes.fr/hal-00945425